Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Lyell Immunopharma Inc shares valued at $115,220 were purchased by Ramachandra Sumant on Mar 21 ’25. At $0.58 per share, Ramachandra Sumant acquired 200,000 shares. The insider’s holdings grew to 200,000 shares worth approximately $0.11 million following the completion of this transaction.
Also, Klausner Richard purchased 158,000 shares, netting a total of over 94,942 in proceeds. Following the buying of shares at $0.60 each, the insider now holds 843,365 shares.
Before that, Newton Charles W. had added 200,000 shares to its account. In a trade valued at $111,620, the Chief Financial Officer bought Lyell Immunopharma Inc shares for $0.56 each. Upon closing the transaction, the insider’s holdings increased to 200,000 shares, worth approximately $0.11 million.
As published in a research note from BofA Securities on October 30, 2024, Lyell Immunopharma Inc [LYEL] has been rated down from a Buy to an Underperform and the price target has been revised to $1 from $6. Analysts at H.C. Wainwright downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in late June. As of August 28, 2023, JP Morgan has decreased its “an Overweight” rating to a “Neutral” for LYEL. Earlier on November 14, 2022, Morgan Stanley downgraded its rating. Their new recommendation was “an Equal-weight” for LYEL stock which previously was a “an Overweight”.
Analyzing LYEL Stock Performance
During the last five days, there has been a drop of approximately -4.13%. Over the course of the year, Lyell Immunopharma Inc shares have dropped approximately -12.84%. Shares of the company reached a 52-week high of $0.7809 on 03/07/25 and a 52-week low of $0.4810 on 03/18/25. A 50-day SMA is recorded $0.6109, while a 200-day SMA reached $1.1202.
Support And Resistance Levels for Lyell Immunopharma Inc (LYEL)
According to the 24-hour chart, there is a support level at 0.5333, which, if violated, would cause prices to drop to 0.5067. In the upper region, resistance lies at 0.5933. The next price resistance is at 0.6267. RSI (Relative Strength Index) is 44.71 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0442, which suggests the price will decrease in the coming days. Percent R is at 73.66%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
